Development of Risk Assessment Criteria for Contamination with Hazardous Substances in Facial Cosmetics
Main Article Content
Abstract
Objective: To develop the criteria for assessing the risk for contamination of hazardous substances (CHS) in facial cosmetics for consumers to use as a tool for self-protection by choosing safe cosmetics, and for authorities to use as a tool in surveillance of CHS. Methods: This research was a cross sectional analytical study in cosmetic samples for facial skin sold in Pakphanang municipality area, Nakhon Si Thammarat. Logistic regression analysis was conducted to identify factors relating to CHS in order to generate regression equation to predict the probability of CHS. The analysis derived 2 criteria for risk assessment (CRA) i.e., CRA for authorities and that for consumers by eliminating some factors difficult for consumers to assess. The study tested the predictive ability of CRAs using analysis of receiver operating characteristic (ROC) curve. Results: 72.34% of cosmetics selling places sold cosmetics with legally violating labels or with no labels, expired or deteriorated cosmetics, or cosmetics with CHS according to the announcement of the Ministry of Public Health. Among 210 cosmetic samples, CHS was found in 127 samples (60.48%). CHS was identified in 31.01% of cosmetics with legally complied labels and in 71.71% of those with legally violating labels or no labels. There were 7 factors significantly related to CHS including misleading labels in the essence of cosmetics, distribution locations (fresh markets, flea markets or stalls), presence of indications for acne, absence of the registration number, absence of lot number, absence of the address of manufacturers/importers, and presence of a fake registration number or the terminated one. CRA for CHS for authorities showed area under the ROC curve (AUC) at 84.80% (95% CI 79.70-90.00). The cosmetics with low risk of CHS (scores 0.0-3.0), medium risk (scores 3.5-9.0) and high risk (9.5-11.5) showed LR at 0.08 (95% CI 0.03-0.20), 1.06 (95% CI 0.80-1.41) และ 9.31 (95% CI 3.51-24.70), respectively with the prevalence of CHS of 11.36, 61.90 and 93.44%, respectively. Three CRAs for consumers showed AUCs at 81.20-83.60% (95% CI 75.30-89.10), sensitivity of 82.70-85.80% and specificity of 65.10-67.50%. Conclusion: CRAs for CHS in facial cosmetics are reliable for predicting the likelihood of CHS with acceptable sensitivity and specificity, despite the removal of some factors difficult for consumers to evaluate. Consumers can therefore use the CRA as a tool in choosing safe cosmetics. Authorities could also use the CRA for surveillance of CHS in cosmetics.
Article Details
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
Cosmetic Control Group, United States Department of Commerce. Thailand - personal care and beauty products [online]. 2017 [cited Oct 6, 2017]. Available from: www.export.gov/article?id=Thailand -personal-care-and-beauty-products.
Office of the consumer protection board. Annual report 2014 - 2015 [online]. 2017 [cited Oct 5, 2017]. Available from: www.ocpb.go.th/more_news. php?cid=20.
Health product vigilance center, Ministry of Public Health. Annual report 2014 - 2016 [online]. 2017 [cited Oct 5, 2017]. Available from: thaihpvc.fda.mo ph.go.th/thaihvc/Public/Webpage/main.jsp.
Sukamolson S, Sriviriyanuparp W, Kulsomboon V. Priority, prevalence and geographic distribution of unsafe products in Thailand. Journal of Health Systems Research 2016; 10: 65-79.
Bureau of Cosmetics and Hazardous Substances, Department of Medical Sciences. Annual report 2015 [online]. 2017 [cited Oct 5, 2017]. Available from: webapp1.dmsc.moph.go.th/itc/annual_report/ pdf/2558/58-cosmetics.pdf.
Cosmetic Act B.E. 2558. Royal Gazette No. 132, Part 86A (Sep 8, 2015).
Boonprachom A, Yukittichai N, Ekkabut N, Pongni mitprasert N, Nuntharatanapong N. Investigation of ammoniated mercury and hydroquinone in whitening creams distributed in Amphur Muang Nakhon Pathom province. Thai Bulletin of Pharma ceutical Sciences 2013; 8: 1-8.
Singchongchai P. Principles and using multivariate statistics analysis for nursing research. 3rd ed. Songkhla: Chanmuang Press; 2006.
Prasongkool K, Ruengorn C. Analysis of the situation on contamination of prohibited harmful substances in facial cosmetics in Amphur Nangrong, Buriram province during 2013-2016. Thai Journal of Phar macy Practice 2017; 9: 361-9.
Klinsoonthorn N, Nutsatapana C, Khemthong T, Mapradit P. Prohibited substances in acne melasma whitening cosmetic products in lower central provinces during 2010-2013. FDA Journal 2013; 20: 28-36.
Karimollah HT. Sample size estimation in diagnostic test studies of biomedical informatics. J Biomed Inform 2014; 48: 193-204.
Kumar R, Indrayan A. Receiver operating charac teristic (ROC) curve for medical researchers. Indian J Pediatr 2011; 48: 277-86.
Hosmer DW, Lemeshow S. Applied logistic regres sion. 2nd ed. New York: A Wiley-Interscience Publi- cation; 2000.
Iamprakhon B. A Proposed method to compare areas under the ROC curves for a single dataset: A case study of credit scoring model [master thesis]. Bangkok: Chulalongkorn University; 2017.
Srisawad S. The predictive accuracy and optimal cut point of citation-based journal metrics to number of citations on Scopus nursing journals: comparison between SJR Indicator and citations per document. TLA Research Journal 2018; 11: 30-44.
Akobeng AK. Understanding diagnostic tests 2: likelihood ratios, pre- and post-test probabilities and their use in clinical practice. Acta Paediatr 2006; 96: 487-91.
Ruengorn C, Nanta S. Steps for developing a screening tool by using clinical prediction rules: a case study from a screening tool for attempted suicide in bipolar patients. Bulletin of Suanprung 2015; 31: 56-71.
Wutthiadirek W, Poomkat W. Study of mercury levels in facial creams distributed in Nakhonsawan municipality area. FDA Journal 2016; 23: 28-33.
Thongsookdee S, Nooda N, Worapranee T. Situation and management of cosmetic safety in Sukhothai province. FDA Journal 2018; 25: 61-71.